Rosa Miceli

Atogepant for the Preventive Treatment of Migraine

Jessica Ailani, Richard B. Lipton, Peter J. Goadsby et al. · New England Journal of Medicine · 2021 · 310 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Urania Rappo, Sailaja Puttagunta, V. G. Shevchenko et al. · Open Forum Infectious Diseases · 2018 · 207 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial

Patricia Pozo‐Rosich, Jessica Ailani, Messoud Ashina et al. · The Lancet · 2023 · 133 citations

Medicine, Neurology, Preventive Medicine +9

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial

Messoud Ashina, Stewart J. Tepper, Uwe Reuter et al. · Headache The Journal of Head and Face Pain · 2023 · 67 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Time course of efficacy of atogepant for the preventive treatment of migraine: Results from the randomized, double-blind ADVANCE trial

Todd J. Schwedt, Richard B. Lipton, Jessica Ailani et al. · Cephalalgia · 2021 · 59 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14